In clinical samples from the TCGA HNSCC cohort, no significant difference in CREBBP (Supplementary Fig. 7c) or EP300 (Supplementary Fig. 7d) gene expression was observed in mutant tumors. This evidence concerns the gene CREBBP and head and neck squamous cell carcinoma.